Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones

Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones

US Patent 11021508 · Granted Jun 1, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2025
Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2022
Use of avermectin derivative for increasing bioavailability and efficacy of macr2021
Use of avermectin derivative for increasing bioavailability and efficacy of macr2021
Use of avermectin derivative for increasing bioavailability and efficacy of macr2021
Markers to predict macrocyclic lactone drug resistance in dirofilaria immitis, t2018
Macrocyclic lactone resistance marker for dirofilaria immitis2014
Methods for detecting and reversing resistance to macrocyclic lactone compounds2008
Methods for detecting and reversing resistance to macrocyclic lactone compounds2003
Methods for detecting and reversing resistance to macrocyclic lactone compounds2002
Methods for using macrocyclic lactone compounds as multidrug resistance reversin2000